An Update on COVID-19 and MS: Disease-Modifying Therapies and COVID Vaccines

online

As coronavirus disease 19 (COVID-19) continues to be a worldwide pandemic, it affects many aspects of healthcare. Specifically, many patients with multiple sclerosis (MS) take medications that alter or suppress ...

As coronavirus disease 19 (COVID-19) continues to be a worldwide pandemic, it affects many aspects of healthcare. Specifically, many patients with multiple sclerosis (MS) take medications that alter or suppress their immune system. Rightly, they and their treatment team are concerned about the safest, but also most effective treatment strategy that considers both MS and the risk of COVID-19.

This program provides an update on our previous activity titled: Safe and Effective Use of MS Disease-Modifying Therapies During the COVID-19 Crisis by discussing updates on the impact of various MS disease-modifying therapies and risk of COVID infection, updates on the vaccines approved and in development to prevent COVID-19 infection, and special consideration for vaccine administration for patients on MS disease-modifying therapies.

Physicians caring for patients with MS during this period of COVID-19 risk require educational programs such as this to stay informed in an effort to provide the best care possible with their MS patients.

---

Write the first review

Resource tags